Literature DB >> 3656604

Dipstick leukocyte esterase activity in first-catch urine specimens. A useful screening test for detecting sexually transmitted disease in the adolescent male.

M D Sadof1, E R Woods, S J Emans.   

Abstract

Although sexually active female adolescents are often routinely screened for sexually transmitted diseases, indications for culturing adolescent males for sexually transmitted urethral infections are controversial. A study of 54 sexually active males (14 to 22 years old) was undertaken to assess the reliability of using dipstick leukocyte esterase activity in first-catch urine specimens to detect urethritis caused by Neisseria gonorrhoeae and Chlamydia trachomatis. Eighteen males had sexually transmitted diseases: N gonorrhoeae (nine patients), C trachomatis (eight patients), and N gonorrhoeae and C trachomatis (one patient). First-catch urine specimens with a 1+ (mild) or 2+ (moderate) reaction on dipstick testing had a leukocyte (WBC) count of 10 WBCs per high-power field or greater on microscopic analysis, with an 83% sensitivity, 100% specificity, a 100% positive predictive value, and a 92% negative predictive value for the presence of N gonorrhoeae, C trachomatis, or both. Clinical criteria for screening (urethral discharge, dysuria, or exposure to a sexually transmitted infection) plus a dipstick-positive first-catch urine specimen had a 94% sensitivity, 89% specificity, an 81% positive predictive value, and a 97% negative predictive value.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3656604

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  10 in total

1.  The potential role of custody facilities in controlling sexually transmitted diseases.

Authors:  D Cohen; R Scribner; J Clark; D Cory
Journal:  Am J Public Health       Date:  1992-04       Impact factor: 9.308

2.  Screening for Chlamydia trachomatis in adolescent males: a cost-based decision analysis.

Authors:  A G Randolph; A E Washington
Journal:  Am J Public Health       Date:  1990-05       Impact factor: 9.308

3.  Rapid screening and treatment for sexually transmitted diseases in arrestees: a feasible control measure.

Authors:  J F Beltrami; D A Cohen; J T Hamrick; T A Farley
Journal:  Am J Public Health       Date:  1997-09       Impact factor: 9.308

4.  Unsatisfactory performance of the leukocyte esterase test of first voided urine for rapid diagnosis of urethritis.

Authors:  D M Patrick; M L Rekart; L Knowles
Journal:  Genitourin Med       Date:  1994-06

5.  Leukocyte esterase urine strips for the screening of men with urethritis--use in developing countries.

Authors:  M W Tyndall; J Nasio; G Maitha; J O Ndinya-Achola; F A Plummer; J W Sellors; K E Luinstra; D Jang; J B Mahony; M A Chernesky
Journal:  Genitourin Med       Date:  1994-02

6.  Use of a leukocyte esterase dipstick to detect Chlamydia trachomatis and Neisseria gonorrhoeae urethritis in asymptomatic adolescent male detainees.

Authors:  S F O'Brien; T A Bell; J A Farrow
Journal:  Am J Public Health       Date:  1988-12       Impact factor: 9.308

7.  Use of a urine enzyme immunoassay as a diagnostic tool for Chlamydia trachomatis urethritis in men.

Authors:  J R Schwebke; A M Clark; M B Pettinger; P Nsubga; W E Stamm
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

8.  Screening for Chlamydia trachomatis in military personnel by urine testing.

Authors:  A Stary; K Steyrer; C Heller-Vitouch; I Müller; P A Mårdh
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

9.  The value of urine specimens in screening for male urethritis and its microbial aetiologies in Tanzania.

Authors:  P Mayaud; J Changalucha; H Grosskurth; G Ka-Gina; J Rugemalila; J Nduba; J Newell; R Hayes; D Mabey
Journal:  Genitourin Med       Date:  1992-12

10.  Neutrophil enzymes in urine for the detection of urethral infection in men.

Authors:  P A Fraser; J Teasdale; K S Gan; R Eglin; S C Scott; C J Lacey
Journal:  Genitourin Med       Date:  1995-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.